Загрузка...
Development of Novel Immunotherapies for Multiple Myeloma
Multiple myeloma (MM) is a disorder of terminally differentiated plasma cells characterized by clonal expansion in the bone marrow (BM). It is the second-most common hematologic malignancy. Despite significant advances in therapeutic strategies, MM remains a predominantly incurable disease emphasizi...
Сохранить в:
| Опубликовано в: : | Int J Mol Sci |
|---|---|
| Главные авторы: | , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
MDPI
2016
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5037783/ https://ncbi.nlm.nih.gov/pubmed/27618026 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms17091506 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|